Company intelligence / Profile preview
Taysha Gene Therapies
Dallas, Texas, United Statestayshagtx.com ↗
- Ownership
- Public · TSHA
- Employees
- ~73
- Development stage
- Phase 1
01
Overview
TSHA-102 for Rett syndrome is in Phase 1/2 REVEAL trials for both adolescent/adult and pediatric patients. As of February 2025, dosing of 10 patients in Part A of both REVEAL trials has been completed, including six patients in cohort two (high dose) and four patients in cohort one (low dose). The therapy was generally well tolerated with no treatment-related serious adverse events or dose-limiting toxicities reported as of February 17, 2025[6][9].
- Therapeutic areas
- Rare DiseasesNeurology
- Modalities
- AAV-based gene therapiesGene replacement therapy (GRT)
- Industry
- Biotech
02
Drug pipeline
27 assets26 more assets in the full pipeline.
03
Partnerships
Astellas (strategic investment)Catalent (manufacturing partnership)UT Southwestern Medical Center (research collaboration and license agreement)
04
Financials
- Market cap
- $1.3B
- Total revenue
- $9.8M
- Enterprise value
- $928.8M
Beyond the preview
Go deeper on Taysha Gene Therapies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Taysha Gene Therapies.